MEDCL.PA
MedinCell S.A.
ParisEUREQUITY
Healthcare
DELAYED
Last price
24.72
▲ 0.60 (2.49%)
MARKET · —
Price
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
24.22
Prev close
24.12
Day high
24.78
Day low
24.06
Volume
40.98K
Market cap
$893.48M
P/E (TTM)
—
52W range
16.64 – 39.68
Trailing performance
Returnvs SPY
1W
+3.24%
+4.6%
1M
-3.27%
-7.0%
3M
-6.75%
-9.8%
6M
+0.81%
-10.3%
YTD
-1.27%
-13.6%
1Y
+43.40%
+23.4%
3Y
+266.42%
+192.3%
5Y
+176.14%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on MEDCL.PA open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
12.21M
Total on file
Fundamentals
Market cap$893.48M
Enterprise value$880.57M
Revenue (TTM)$24.28M
Gross profit$24.28M
EBITDA$-20.04M
Net income$-31.29M
EPS (TTM)$-0.94
Free cash flow$-19.78M
Total cash$84.82M
Total debt$71.92M
Book value / share$0.09
Shares outstanding35.91M
Float32.79M
Short % of float—
Dividend yield—
Beta (5Y)0.98
Valuation & profitability ratios
Trailing P/E—
Forward P/E59.24
PEG ratio—
Price / sales—
Price / book292.71
EV / revenue36.27
EV / EBITDA-43.95
Gross margin100.00%
Operating margin-139.50%
Profit margin-128.88%
Return on equity—
Return on assets-13.06%
Debt / equity2,347.10
Current ratio4.67
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $19.52M | $25.54M | $9.16M | $9.94M | — | -23.6% |
| Operating revenue | $19.52M | $25.54M | $9.16M | $9.94M | — | -23.6% |
| Cost of revenue | $0 | $0 | $0 | $0 | — | — |
| Gross profit | $19.52M | $25.54M | $9.16M | $9.94M | — | -23.6% |
| Research & development | $26.54M | $24.31M | $21.08M | $27.93M | — | +9.2% |
| Selling, general & admin | — | $529.00K | $557.00K | $629.00K | $732.00K | — |
| Total operating expense | $40.30M | $36.38M | $30.14M | $33.99M | — | +10.8% |
| Operating income | -$20.78M | -$10.84M | -$20.98M | -$24.05M | — | -91.7% |
| Net interest income | -$11.02M | -$8.61M | -$4.66M | -$9.17M | — | -28.0% |
| Pre-tax income | -$31.36M | -$18.28M | -$24.95M | -$32.01M | — | -71.6% |
| Tax provision | -$69.00K | $160.00K | $88.00K | $0 | — | -143.1% |
| Net income | -$31.29M | -$18.44M | -$25.04M | -$32.01M | — | -69.7% |
| Net income to common | -$31.29M | -$18.44M | -$25.04M | -$32.01M | — | -69.7% |
| Basic EPS | -0.94 | -0.62 | -0.86 | -1.27 | — | -51.6% |
| Diluted EPS | -0.94 | -0.62 | -0.86 | -1.27 | — | -51.6% |
| EBIT | -$25.85M | -$13.19M | -$20.33M | -$28.08M | — | -96.0% |
| EBITDA | -$24.02M | -$11.20M | -$18.61M | -$26.41M | — | -114.5% |
| Basic shares | 33.37M | 29.64M | 29.07M | 25.19M | — | +12.6% |
| Diluted shares | 33.37M | 29.64M | 29.07M | 25.19M | — | +12.6% |
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $62.79M | $59.04M | $19.46M | $6.47M | — | +6.4% |
| Cash & short-term investments | $84.82M | $71.90M | $19.46M | $6.47M | — | +18.0% |
| Accounts receivable | $1.63M | $1.42M | $1.47M | $2.09M | — | +15.0% |
| Inventory | — | — | — | $0 | $0 | — |
| Total current assets | $96.74M | $80.62M | $27.26M | $19.57M | — | +20.0% |
| Property, plant & equipment | $5.00M | $5.27M | $5.43M | $6.37M | — | -5.3% |
| Goodwill & intangibles | $3.48M | $2.65M | $2.45M | $1.93M | — | +31.5% |
| Total assets | $108.06M | $90.45M | $36.95M | $29.34M | — | +19.5% |
| Total current liabilities | $20.71M | $29.87M | $16.47M | $57.02M | — | -30.7% |
| Current debt | $2.63M | $6.62M | $5.52M | $39.76M | — | -60.2% |
| Long-term debt | $52.39M | $49.41M | $50.54M | $11.71M | — | +6.0% |
| Total debt | $57.41M | $58.76M | $58.96M | $54.65M | — | -2.3% |
| Total liabilities | $104.99M | $106.82M | $77.77M | $71.63M | — | -1.7% |
| Retained earnings | -$31.29M | -$18.44M | -$25.04M | -$32.01M | — | -69.7% |
| Shareholder equity | $3.06M | -$16.37M | -$40.82M | -$42.29M | — | +118.7% |
| Working capital | $76.02M | $50.74M | $10.79M | -$37.46M | — | +49.8% |
| Net tangible assets | -$416.00K | -$19.01M | -$43.27M | -$44.22M | — | +97.8% |
| Shares issued | 35.91M | 33.07M | 29.09M | 25.29M | — | +8.6% |
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$31.29M | -$18.44M | -$25.04M | -$32.01M | — | -69.7% |
| Depreciation & amortisation | $1.82M | $1.99M | $1.72M | $1.67M | — | -8.3% |
| Stock-based compensation | $5.21M | $2.96M | $2.81M | $2.28M | — | +75.9% |
| Change in working capital | -$9.77M | $24.53M | $3.18M | -$3.04M | — | -139.8% |
| Operating cash flow | -$24.55M | $19.46M | -$11.92M | -$21.00M | — | -226.1% |
| Capital expenditure | -$2.04M | -$1.66M | -$1.19M | -$1.03M | — | -23.1% |
| Investing cash flow | -$10.51M | -$13.21M | -$613.00K | $1.30M | — | +20.5% |
| Share buybacks | — | — | -$25.00K | — | -$192.00K | — |
| Financing cash flow | $38.82M | $33.32M | $25.53M | $1.56M | — | +16.5% |
| Free cash flow | -$26.60M | $17.80M | -$13.11M | -$22.03M | — | -249.4% |
| End cash position | $62.79M | $59.04M | $19.46M | $6.47M | — | +6.4% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2026-03-31 | 2025-09-30 | 2025-03-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $62.79M | $49.77M | $59.04M | +26.2% |
| Cash & short-term investments | $84.82M | $53.50M | $71.90M | +58.5% |
| Accounts receivable | $1.63M | $830.00K | $1.42M | +96.4% |
| Total current assets | $96.74M | $61.36M | $80.62M | +57.7% |
| Property, plant & equipment | $5.00M | $4.84M | $5.27M | +3.2% |
| Goodwill & intangibles | $3.48M | $3.03M | $2.65M | +14.7% |
| Total assets | $108.06M | $74.58M | $90.45M | +44.9% |
| Total current liabilities | $20.71M | $21.33M | $29.87M | -2.9% |
| Current debt | $2.63M | $4.98M | $6.62M | -47.1% |
| Long-term debt | $52.39M | $50.83M | $49.41M | +3.1% |
| Total debt | $57.41M | $58.27M | $58.76M | -1.5% |
| Total liabilities | $104.99M | $105.21M | $106.82M | -0.2% |
| Retained earnings | -$31.29M | -$16.08M | -$18.44M | -94.6% |
| Shareholder equity | $3.06M | -$30.63M | -$16.37M | +110.0% |
| Working capital | $76.02M | $40.02M | $50.74M | +89.9% |
| Net tangible assets | -$416.00K | -$33.66M | -$19.01M | +98.8% |
| Shares issued | 35.91M | 33.10M | 33.07M | +8.5% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Sep 2025 | -0.18 | — | — |
| Jun 2025 | -0.15 | — | — |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | 0.05 | 5 | $44.14M | +81.8% |
| Next year | 0.42 | 5 | $58.92M | +33.5% |
Analyst targets & ownership
Mean target$34.51
High target$39.00
Low target$30.00
Implied upside39.61%
Analyst count9
ConsensusSTRONG BUY
Strong buy / Buy0 / 9
Hold0
Sell / Strong sell0 / 0
Held by insiders33.99%
Held by institutions31.75%
Institutions holding61
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
24.47
+1.01% from price
SMA 20
24.95
-0.28% from price
SMA 50
25.98
-4.22% from price
SMA 100
25.82
-4.25% from price
SMA 200
25.55
-2.61% from price
EMA 12
24.68
+0.15% from price
EMA 26
25.13
-1.64% from price
EMA 50
25.55
-3.25% from price
RSI (14)
47.7
Neutral
MACD (12,26,9)
-0.45
Hist 0.05
ATR (14)
0.83
3.33% of price
Realised vol 30D
30.2%
Annualised
Bollinger upper
26.30
20, 2σ
Bollinger lower
23.60
20, 2σ
50 / 200 cross
Golden
25.98 vs 25.55
Trend bias
Below 200
-2.61%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.13
Less volatile than market
Correlation to SPY
-0.03
Largely independent
Realised vol 30D
30.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-47.4%
Peak to trough
Max drawdown 5Y
-54.7%
Peak to trough
ATR 14
0.83
3.33% of price
Beta (reported)
0.98
5Y monthly, from filing
Headlines
South Korean survivor fights for workplace harassment 'justice'
AFP · 13m ago
Apple Cut Its Standard EU App Store Commission From 30% to 26%
Motley Fool · 19m ago
Gundir Announces Gundir365(TM) Postage Promise, Locking In Direct Mail Postage Rates for a Full Year
ACCESS Newswire · 32m ago
Why Keysight Technologies Stock Sank This Week
Motley Fool · 39m ago
Sydney marathon unveils medal with wrong stadium
AFP · 42m ago
Atlassian (TEAM) Stock Looks Near Fair Value After Its 98% Run
Simply Wall St. · 46m ago
Is Vestas Wind Systems (CPSE:VWS) Fully Valued As Earnings Lifted Full Year Guidance?
Simply Wall St. · 46m ago
Clorox (CLX) Could Be 56% Below Fair Value As Valuation Views Split
Simply Wall St. · 46m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.